Suivre
Stefan Mühlebach
Stefan Mühlebach
Externer Mitarbeiter der Universität Basel
Adresse e-mail validée de unibas.ch
Titre
Citée par
Citée par
Année
ESPEN guidelines on nutrition in cancer patients
J Arends, P Bachmann, V Baracos, N Barthelemy, H Bertz, F Bozzetti, ...
Clinical nutrition 36 (1), 11-48, 2017
31802017
ESPEN practical guideline: Clinical Nutrition in cancer
M Muscaritoli, J Arends, P Bachmann, V Baracos, N Barthelemy, H Bertz, ...
Clinical Nutrition 40 (5), 2898-2913, 2021
8342021
ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients
M Staun, L Pironi, F Bozzetti, J Baxter, A Forbes, F Joly, P Jeppesen, ...
Clinical nutrition 28 (4), 467-479, 2009
5732009
Nanomedicines: addressing the scientific and regulatory gap
S Tinkle, SE McNeil, S Mühlebach, R Bawa, G Borchard, Y Barenholz, ...
Annals of the New York Academy of Sciences 1313 (1), 35-56, 2014
5382014
Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer
I Schwegler, A Von Holzen, JP Gutzwiller, R Schlumpf, S Mühlebach, ...
Journal of British Surgery 97 (1), 92-97, 2010
4942010
ESPEN guideline on home parenteral nutrition
L Pironi, K Boeykens, F Bozzetti, F Joly, S Klek, S Lal, M Lichota, ...
Clinical nutrition 39 (6), 1645-1666, 2020
2362020
The therapeutic equivalence of complex drugs
H Schellekens, E Klinger, S Mühlebach, JF Brin, G Storm, DJA Crommelin
Regulatory Toxicology and Pharmacology 59 (1), 176-183, 2011
1582011
Managing the patient journey through enteral nutritional care
P Howard, C Jonkers-Schuitema, L Furniss, U Kyle, S Muehlebach, ...
Clinical nutrition 25 (2), 187-195, 2006
1402006
How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider
H Schellekens, S Stegemann, V Weinstein, JSB de Vlieger, B Flühmann, ...
The AAPS journal 16, 15-21, 2014
1362014
Regulatory challenges of nanomedicines and their follow-on versions: a generic or similar approach?
S Mühlebach
Advanced drug delivery reviews 131, 122-131, 2018
1142018
Nanomedicines: The magic bullets reaching their target?
B Flühmann, I Ntai, G Borchard, S Simoens, S Mühlebach
European Journal of Pharmaceutical Sciences 128, 73-80, 2019
1112019
The similarity question for biologicals and non-biological complex drugs
DJA Crommelin, VP Shah, I Klebovich, SE McNeil, V Weinstein, ...
European Journal of Pharmaceutical Sciences 76, 10-17, 2015
972015
Neonatology/paediatrics–Guidelines on parenteral nutrition, Chapter 13
C Fusch, K Bauer, HJ Böhles, F Jochum, B Koletzko, M Krawinkel, ...
GMS german medical science 7, 2009
922009
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks
L Hussaarts, S Mühlebach, VP Shah, S McNeil, G Borchard, B Flühmann, ...
Annals of the New York Academy of Sciences 1407 (1), 39-49, 2017
832017
Nanoparticle iron medicinal products–Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies
G Borchard, B Flühmann, S Mühlebach
Regulatory Toxicology and Pharmacology 64 (2), 324-328, 2012
832012
Implementation of treatment guidelines to support judicious use of antibiotic therapy
S Deuster, I Roten, S Muehlebach
Journal of clinical pharmacy and therapeutics 35 (1), 71-78, 2010
802010
Lipid peroxidation of iv lipid emulsions in TPN bags: the influence of tocopherols
PJK Steger, SF Mühlebach
Nutrition 14 (2), 179-185, 1998
801998
Different pharmaceutical products need similar terminology
DJA Crommelin, JSB de Vlieger, V Weinstein, S Mühlebach, VP Shah, ...
The AAPS journal 16, 11-14, 2014
772014
Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars
S Mühlebach, G Borchard, S Yildiz
Nanomedicine 10 (4), 659-674, 2015
702015
Pharmacokinetics in rats of 2, 4, 5, 2′, 4′, 5-hexachlorobiphenyl, an unmetabolizable lipophilic model compound
S Mühlebach, MH Bickel
Xenobiotica 11 (4), 249-257, 1981
681981
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20